In a pivotal gathering that notably lacked male presence, the Women in AI Healthcare event, a collaboration between Real Chemistry and Pharma Brands, united a dynamic cohort of female leaders to delve into the revolutionary impact of artificial intelligence (AI) in the realm of life sciences. This event not only served as a showcase of innovation but also as a clarion call for ensuring that women are not just participants but central figures in shaping the future landscape of AI in healthcare.
With just 22% of AI professionals in the UK being women, the urgency to tackle this gender imbalance within the field is starkly evident. The potential consequences of AI systems being predominantly trained on male-centric data sets are profound, as they risk perpetuating gender biases that could have far-reaching implications, particularly in healthcare settings. Celine Parmentier, EVP and head of global med comms at Real Chemistry, underscored the critical importance of women’s involvement in the design, testing, and deployment of AI to avoid these gaps.
The event featured a lineup of distinguished speakers, each a trailblazer in her own right, who exemplified how women are actively influencing, challenging, and advocating for the integration of AI in life sciences. Bobby Dhaliwal, the innovation and business excellence director, UK, at AstraZeneca, set the tone with a bold statement, highlighting that AI represents the most significant workplace transformation in the past 25 years. Her journey from a self-professed ‘rubbish’ chemist to a leader spearheading AI capability uplift programs at AstraZeneca showcased the value of curiosity and adaptability in navigating technological advancements.
Heather Murray, the founder and CEO of AI for Non-Techies, provided invaluable insights by demystifying the complex realm of AI into six practical categories. Murray emphasized that while AI is not a new concept, its increasing accessibility is reshaping various industries. She emphasized the risks associated with ‘Shadow AI’ and advocated for creating safe spaces where women can experiment and lead in AI adoption within organizations.
Dr. Samin Saeed, the VP of early medical pipeline, specialty care, at GSK, provided a strategic perspective on AI’s role in reshaping Medical Affairs. She highlighted the significant potential of AI in providing insights, evidence generation, and shaping clinical narratives while cautioning against overreliance and underscoring the indispensable need for human oversight in critical processes.
The interactive nature of the event facilitated robust discussions covering a wide array of topics, from adoption rates and ethical considerations to environmental impacts and the evolving roles of humans in the AI landscape. Concerns were raised regarding the limitations of certain AI tools and the imperative need for diverse toolsets and flexible governance structures to navigate the evolving AI terrain successfully.
As the event drew to a close, the resounding consensus was clear: women must not only be active participants in the AI journey but must also hold key roles as designers, testers, and decision-makers in shaping AI’s trajectory in life sciences. The imperative need for intentional spaces for women in AI, along with proactive upskilling initiatives and gender-specific sessions, emerged as essential factors in fostering a more inclusive and ethical AI transformation within the industry.
In a world increasingly influenced by algorithms, the ability to pose the right questions with confidence is becoming a pivotal skill that will define the future of work. The women leading the charge in AI innovation within life sciences are not merely observers in this transformative journey; they are the vanguards driving the industry towards a more inclusive, ethical, and diverse future powered by AI.
As AI continues to evolve, the imperative for the life sciences sector is to ensure that this transformation remains inclusive, ethical, and representative of diverse perspectives. The women at the forefront of the AI revolution in life sciences are not just shaping this journey – they are pioneering it with resilience, ingenuity, and unwavering determination.
Tags: automation
Read more on pharmaphorum.com